Stay updated with breaking news from Director Eric. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Investment House LLC reduced its holdings in Biogen Inc. (NASDAQ:BIIB – Free Report) by 2.0% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 3,269 shares of the biotechnology company’s stock after selling 67 shares during the quarter. Investment House LLC’s holdings in […]
In March, broadcast journalists from Virginia and West Virginia were recognized when the Virginias Associated Press Broadcasters met to present awards for notable stories produced in 2023. This week, we listen back to some of our award-winning stories.
Biogen (NASDAQ:BIIB – Free Report) had its target price upped by Wedbush from $213.00 to $215.00 in a report published on Thursday morning, Benzinga reports. They currently have a neutral rating on the biotechnology company’s stock. Wedbush also issued estimates for Biogen’s Q2 2024 earnings at $3.43 EPS, Q4 2024 earnings at $4.30 EPS, FY2024 […]
Biogen (NASDAQ:BIIB – Free Report) had its target price trimmed by Barclays from $215.00 to $200.00 in a report published on Thursday morning, Benzinga reports. They currently have an equal weight rating on the biotechnology company’s stock. BIIB has been the topic of several other research reports. Wedbush upped their target price on Biogen from […]
Gitterman Wealth Management LLC purchased a new stake in Biogen Inc. (NASDAQ:BIIB – Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund purchased 980 shares of the biotechnology company’s stock, valued at approximately $254,000. Other institutional investors have also added to or reduced […]